» Articles » PMID: 29992137

Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Jul 12
PMID 29992137
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a common, chronic, and autoimmune skin disease. Factors that play a role in etiopathogenesis of psoriasis include internal factors such as genetic susceptibility and immunological factors and external factors such as stress, infection, trauma, drug, and environmental compounds. N-acetyltransferase 2 (NAT2) is a xenobiotic enzyme that is involved in the metabolism of drugs, environmental toxins, and carcinogens. In this study, we aimed to demonstrate whether the variations in the gene lead to a predisposition to psoriasis by affecting the enzyme's ability to metabolize drugs and environmental components or not. Three polymorphisms (, and ) in gene were genotyped and compared by real-time PCR method in 260 psoriasis vulgaris patients and 200 healthy controls. There was no difference in the genotype distributions and allele frequencies of polymorphisms between psoriasis vulgaris patients and controls. When the effects of polymorphisms on the clinical features of the disease, such as onset age and severity, are assessed, it has been found that and are, respectively, associated with early onset age and severity of the disease. In conclusion, , and polymorphisms of the NAT-2 gene do not appear to be a risk factor for the development of psoriasis. Conversely, they may have an effect on either more severe or early onset cases of the disease.

Citing Articles

Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.

Tebien E, Khalil H, Mills J, Elderdery A Asian Pac J Cancer Prev. 2020; 21(12):3711-3717.

PMID: 33369472 PMC: 8046315. DOI: 10.31557/APJCP.2020.21.12.3711.

References
1.
Salimi S, Nakhaee A, Jafari M, Jahantigh D, Sandooghi M, Zakeri Z . Combination Effect of GSTM1, GSTT1 and GSTP1 Polymorphisms and Risk of Systemic Lupus Erythematosus. Iran J Public Health. 2015; 44(6):814-21. PMC: 4524306. View

2.
Prieto-Perez R, Solano-Lopez G, Cabaleiro T, Roman M, Ochoa D, Talegon M . Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis. J Immunol Res. 2015; 2015:101879. PMC: 4647058. DOI: 10.1155/2015/101879. View

3.
Vojdani A, Pollard K, Campbell A . Environmental triggers and autoimmunity. Autoimmune Dis. 2015; 2014:798029. PMC: 4290643. DOI: 10.1155/2014/798029. View

4.
Oqal M, Mustafa K, Irshaid Y . N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital. Genet Test Mol Biomarkers. 2012; 16(9):1007-10. PMC: 3438808. DOI: 10.1089/gtmb.2012.0062. View

5.
Kozhekbaeva Z, Gra O, Fadeev V, Goldenkova-Pavlova I, Korsunskaia I, Bruskin S . [Association of NAT2 polymorphism with risks to develop psoriasis and various dermatological diseases in Moscow population]. Mol Biol (Mosk). 2009; 43(1):62-76. View